Suppr超能文献

人神经干细胞在早期慢性脊髓损伤 NOD-scid 小鼠模型中分化并促进运动功能恢复。

Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model.

机构信息

Department of Anatomy and Neurobiology, University of California Irvine, Irvine, California, United States of America.

出版信息

PLoS One. 2010 Aug 18;5(8):e12272. doi: 10.1371/journal.pone.0012272.

Abstract

BACKGROUND

Traumatic spinal cord injury (SCI) results in partial or complete paralysis and is characterized by a loss of neurons and oligodendrocytes, axonal injury, and demyelination/dysmyelination of spared axons. Approximately 1,250,000 individuals have chronic SCI in the U.S.; therefore treatment in the chronic stages is highly clinically relevant. Human neural stem cells (hCNS-SCns) were prospectively isolated based on fluorescence-activated cell sorting for a CD133(+) and CD24(-/lo) population from fetal brain, grown as neurospheres, and lineage restricted to generate neurons, oligodendrocytes and astrocytes. hCNS-SCns have recently been transplanted sub-acutely following spinal cord injury and found to promote improved locomotor recovery. We tested the ability of hCNS-SCns transplanted 30 days post SCI to survive, differentiate, migrate, and promote improved locomotor recovery.

METHODS AND FINDINGS

hCNS-SCns were transplanted into immunodeficient NOD-scid mice 30 days post spinal cord contusion injury. hCNS-SCns transplanted mice demonstrated significantly improved locomotor recovery compared to vehicle controls using open field locomotor testing and CatWalk gait analysis. Transplanted hCNS-SCns exhibited long-term engraftment, migration, limited proliferation, and differentiation predominantly to oligodendrocytes and neurons. Astrocytic differentiation was rare and mice did not exhibit mechanical allodynia. Furthermore, differentiated hCNS-SCns integrated with the host as demonstrated by co-localization of human cytoplasm with discrete staining for the paranodal marker contactin-associated protein.

CONCLUSIONS

The results suggest that hCNS-SCns are capable of surviving, differentiating, and promoting improved locomotor recovery when transplanted into an early chronic injury microenvironment. These data suggest that hCNS-SCns transplantation has efficacy in an early chronic SCI setting and thus expands the "window of opportunity" for intervention.

摘要

背景

外伤性脊髓损伤(SCI)导致部分或完全瘫痪,其特征是神经元和少突胶质细胞丢失、轴突损伤以及未受影响的轴突脱髓鞘/发育不良。美国约有 125 万人患有慢性 SCI;因此,慢性阶段的治疗具有高度的临床相关性。人神经干细胞(hCNS-SCns)是根据荧光激活细胞分选技术从胎脑中分离出来的,具有 CD133(+)和 CD24(-/lo)表型,生长为神经球,并通过谱系限制生成神经元、少突胶质细胞和星形胶质细胞。最近,hCNS-SCns 在脊髓损伤后亚急性移植,并发现可促进运动功能恢复。我们测试了 hCNS-SCns 在 SCI 后 30 天移植后的存活、分化、迁移能力,以及促进运动功能恢复的能力。

方法和发现

hCNS-SCns 在脊髓挫伤损伤后 30 天移植到免疫缺陷型 NOD-scid 小鼠中。与载体对照组相比,hCNS-SCns 移植组在旷场运动测试和 CatWalk 步态分析中表现出显著改善的运动功能恢复。移植的 hCNS-SCns 表现出长期的植入、迁移、有限的增殖和分化,主要分化为少突胶质细胞和神经元。星形胶质细胞分化很少见,并且小鼠没有表现出机械性痛觉过敏。此外,分化的 hCNS-SCns 与宿主整合,表现为人类细胞质与离散的连接蛋白相关蛋白( paranodal marker contactin-associated protein)的共定位。

结论

这些结果表明,hCNS-SCns 在移植到早期慢性损伤微环境中时,能够存活、分化并促进运动功能恢复。这些数据表明,hCNS-SCns 移植在早期慢性 SCI 中具有疗效,从而扩大了干预的“机会窗口”。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eceb/2923623/18efcc15cc78/pone.0012272.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验